GlassScriptPhysician profile
Aneel Henry
NPI 1639661564
$3,584.75
in general payments reported to CMS, 2019-2025
21 companies · $1,567 in 2025
The $1,567 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.75 · 2023: $127 · 2024: $1,871 · 2025: $1,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,565.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $918.25 | 2024-2025 | Injectafer |
| Novo Nordisk INC | $566.55 | 2023-2025 | Wegovy, Ozempic, Saxenda |
| Gilead Sciences, INC. | $412.54 | 2023-2025 | |
| Viiv Healthcare Company | $409.72 | 2024-2025 | Apretude |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.73 | 2024-2025 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $175.80 | 2024-2025 | |
| Phadia US INC. | $132.58 | 2024 | Immunocap |
| Pfizer INC. | $128.82 | 2023-2025 | |
| Hologic Sales and Service, LLC | $114.16 | 2024-2025 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $88.18 | 2024-2025 | |
| Glaxosmithkline, LLC. | $74.87 | 2025 | Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $62.33 | 2024 | Cologuard Collection Kit |
| Philips North America LLC | $53.60 | 2024-2025 | Extended Holter, (Ck7) Extended Holter |
| Abbvie INC. | $44.68 | 2023-2025 | |
| Lilly USA, LLC | $28.47 | 2024 | Mounjaro, Zepbound |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $26.59 | 2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.26 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $22.11 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $19.75 | 2019 | |
| Irhythm Technologies, INC. | $18.45 | 2023 | Zio Xt Patch |
| Emd Serono, INC. | $17.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aneel Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.